+1-518-621-2074 | US-Canada Toll Free Contact Us

Global Dialysis Catheters Market Promises Robust Growth amidst Rise of Kidney-Related Illnesses

about us

Published on : Jan 13, 2020

Global dialysis catheters market is expected to witness major growth in the near future, thanks to rise in various kidney-related ailments among others. CKD or Chronic Kidney Disease is extremely prevalent across United States. CKD is found among 15% of US adults, reaching nearly 37 million in total in 2019, according to the center for disease control and prevention. 

Moreover, the number is expected to go up significantly in the near future, as 9 out 10 people are not aware of their condition. Moreover, this includes dialysis for over 50% of the population who currently are not aware that they require the medical treatment. The rising awareness, and innovation in dialysis treatment are expected to drive considerable growth in the near future. 

RMoz has released a new report, titled “Global Dialysis Catheters Market Insights, Forecast to 2026.” The global Dialysis Catheters market is expected to create several new opportunities for new players as technologies like Big Data, rising innovation in genetics, and Artificial Intelligence continue to provide new avenues for growth. The market thoroughly discusses the upcoming robust growth prospects and prominent strategies implicated by several key players operating in the global Dialysis Catheters market. These drivers are key to understanding several new opportunities and challenges that await the current and new players in the Dialysis Catheters market. The report is available on the website ResearchMoz.us as well

New Opportunities for Growth in the Dialysis Catheters Market 

Rising number of patients with end-stage renal disease is a major concern across the world, and especially in United States. It is estimated that majority will require haemodialysis before kidney transplantation. However, doing so wasn’t easy earlier. Conventional procedures were considered unsafe, while resulting in complications. However, new research published in the US National Library of Medicine promises major breakthroughs with safe and life-saving procedure for patients. It has not only resulted in significant reduction in catheter infection but also placement of catheters in external jugular and its safe applications. The growing demand for this treatment before kidney transplantation and its safe application promises new opportunities for players in the global dialysis catheters market. 

Request a Sample PDF copy with detailed Insights: https://www.researchmoz.us/enquiry.php?type=S&repid=2506191

Asia Pacific will Drive Largest Growth in the Near Future 

The global dialysis market is divided into key regions including North America, Asia Pacific, Europe, Latin America, and Middle East and Africa. Among these, the Asia Pacific region is expected to hold dominant over the near future. The region held the largest share in the market during the last decade. Moreover, expanding access to healthcare, and expanding coverage of private reimbursement scenario is likely to drive growth. Latin America is also expected to witness considerable growth in the near future, due to rising incidences of renal diseases, and rise in demand for new and efficient medical treatments. The high costs of kidney transplantation and lack of awareness are major barriers for growth in North America region. Procedures like haemodialysis can cost nearly $US90, 000 per patient in the United States. However, the expansion of healthcare coverage in the near future can create robust opportunities for growth in the global dialysis catheters market. 

Some key players in the global dialysis catheters market are The report provides extensive competitive analysis and profiles of key market players, such as Fresenius Medical Care AG & Co. KGaA, Nikkiso Co. Ltd, B. Braun Melsungen AG, Nipro Medical Corporation, Toray Medical Co., Ltd., Baxter International Inc., Asahi Kasei Medical Co., Ltd., NxStage Medical, Inc., Outset Medical, Inc, and Allmed Medical Corporation.